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Methicillin-resistant Staphylococcus aureus has emerged as a pathogen associated with
community-acquired  infections worldwide. We  report the spectrum of community-acquired
S.  aureus infections and compare the patients infected with methicillin-susceptible or
methicillin-resistant  strains among patients aged <20 years. Overall, 90 cases of community-
acquired  S. aureus were detected in an 11-year period. Clinical and microbiological data
were  registered. Fifty-nine (66%) patients were male and the median age was two years.
The  majority (87%) of the patients were hospitalized and chronic underlying illnesses were
detected  in 27 (30%) cases. Overall, 34 (37.8%) patients had skin/soft tissue infections and
56  (62.2%) patients had deep-seated infection. Four (5.1%) patients were transferred to
the  intensive care unit and two (2.6%) died. Complications were detected in 17 (18.9%)
cases,  such as pleural effusion (41.2%), osteomyelitis (23.5%), and sepsis (17.6%). Six (6.7%)
methicillin-resistant strains were detected. Patients infected with methicillin-susceptible or
methicillin-resistant strains had similar baseline characteristics and treatment outcomes.
Approximately  93% of the cases received systemic antibiotics, out of which 59 (65.5%) usedoxacillin  or cefalotin. Both methicillin-susceptible and methicillin-resistant S. aureus strains
resulted  in morbidity and death among children in this setting where methicillin-resistant
strains  are infrequent.
been  observed in many  patient groups, and healthy children
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are  also susceptible.2 Cases of CA-MRSA infection affecting
children without established risk factors started emerging in
1990s.3 Mostly, CA-MRSA infection has been associated not
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only with skin/soft tissue infections (SSTIs), but also with
invasive  infections, which require aggressive treatment and
hospitalization.4
The risk of severe disease caused by CA-MRSA is a real
concern among researchers. In Minnesota and North Dakota,
between  1997 and 1999, four pediatric deaths were associ-
ated  with CA-MRSA strains.5 Many  institutions have reported
their  experience with community-acquired S. aureus (CA-SA)
infection  in children. In a previous study conducted in a pedi-
atric  center in Northeast Brazil 4.9% of isolated CA-SA strains
were  resistant to methicillin.6 Several studies have shown dif-
ferences between MRSA and methicillin-susceptible S. aureus
(MSSA)  infections even after controlling for confounding vari-
ables  such as nosocomial infection.7 A three-year surveillance
of  CA-SA infections at the Texas Children’s Hospital docu-
mented  a greater percentage of CA-MSSA isolates (8.2%) than
CA-MRSA  isolates (4.4%) which were collected from patients
with  invasive infections.8 Recently, a report of CA-SA pneu-
monia  among hospitalized children in Hawaii revealed the
occurrence  of pulmonary complications more  frequently in
MRSA infected patients.9 The objectives of this investigation
were  to describe the spectrum of community-acquired disease
presented  by patients infected with S. aureus and to compare
the  patients infected with MSSA or MRSA strains.
Materials  and  methods
Design  and  study  population
The Ethics Committee of the university hospital at Federal
University of Bahia, Salvador, Brazil, approved this study
(approval  53/2005) which was  a retrospective cohort con-
ducted  in the same hospital. Cultures in which S. aureus
were  isolated from pediatric patients (<20-years-old) between
1994  and 2005 were  identiﬁed in the Bacteriology Laboratory
log-book and the respective medical records were reviewed.
CA-MRSA infections were  selected by applying the follow-
ing  items, according to the Centers for Disease Control and
Prevention  (CDC) criteria last updated in December 2, 2010:
diagnosis  of MRSA in a outpatient setting or by culture
within 48 h after admission to the hospital, with no his-
tory  of MRSA infection or colonization; the patient must
not  have experienced any of the following conditions dur-
ing  the year before infection: hospitalization, admission to a
nursing home, skilled nursing facility, or hospice; dialysis; or
surgery. Furthermore, the patient must be without permanent
indwelling catheters or medical devices that pass through the
skin  into the body.10 S. aureus isolates obtained after 48 h of
admission  from patients with clinical evidence of disease prior
to admission were  also included.8 CA-MSSA cases were con-
sidered  eligible for the study if they met  the same criteria of
CA-MRSA  cases, that is lack of the previously cited healthcare-
associated risk factors.10
Microbiologic  proceduresCultures were  performed manually up to 1999; in 2000,
the  automatic process was  implemented. Both of them
were  in accordance with standardized procedures previously 1 3;1  7(5):573–578
described.11 S. aureus was  identiﬁed by routine procedures,
including catalase and coagulase tests. Antimicrobial resis-
tance  was  examined by the disc-diffusion method according
to  the Clinical and Laboratory Standards Institute.11 In order
to  test for resistance to methicillin, a 1 g oxacillin disc
was  applied to Mueller-Hinton agar containing 5% sodium
chloride and incubated at 35 ◦C.12 Additionally, only ﬂuids
from  which S. aureus was  the only isolated pathogen were
included.
Data  collection  and  analysis
For each case of CA-SA infection, the following medical infor-
mation  was  retrieved: demographics (age, gender); diagnosis;
infection  sites; length of hospitalization, nutritional evalua-
tion,  underlying illnesses, treatment; patients’ outcomes (stay
at a pediatric intensive care unit [ICU], sequela and death).
Additional information about healthcare-associated risk fac-
tors, as proposed by the CDC in 2010,10 at the time of S.
aureus  infection, and sequela was  collected by a phone call
to  the patient’s families between October 2010 and June 2011,
after  receiving oral informed consent. Nutritional evaluation
was  performed by using the software Anthro; malnutri-
tion and severe malnutrition were deﬁned as Z-score for
weight-for-age index under −2.00 and −3.00, respectively.13
Infections were  classiﬁed as SSTIs, such as abscess, celluli-
tis,  or impetigo, and deep-seated (or invasive) infection which
included  bacteremia, meningitis, osteomyelitis, pneumonia,
septic  arthritis, endocarditis or another illness in which S.
aureus  was  isolated from normally sterile body ﬂuids. If a
patient  had both SSTIs and deep-seated infection, the infec-
tion  was  deﬁned as deep-seated.14
Statistical  methods
Statistical analysis was  performed by using SPSS software
for  Windows version 9.0. Descriptive statistics including dis-
tribution,  central tendency and dispersion are presented.
Two-tailed p < 0.05 was  considered signiﬁcant. Comparison
of  continuous variables was  analyzed by using Student t or
Mann–Whitney U-test, according to the variable distribution.
Categorical variables were compared by using Fisher exact test
because the expected frequency was  <5.
Results
Ninety cases of CA-SA were detected; 59 (66%) patients were
male  and the median (25th–75th percentile) age was  two years
(5.4  months–6.2 years). The majority (87%) of the patients were
hospitalized.  Chronic underlying illnesses were  detected in
27  (30%) cases: skin (44.4%), heart (25.9%) respiratory tract
(11.1%),  and central nervous system (3.7%). Additionally, sickle
cell  disease, AIDS, prematurity, and trauma were  diagnosed
(3.7%  each). Twelve (13.3%) cases presented malnutrition, out
of which two (16.7%) were  severely malnourished. Overall,
34  (37.8%) patients had SSTIs (abscess [44.1%], pyodermi-
tis  [41.2%], cellulitis [5.9%], conjunctivitis [2.9%], tonsillitis
[2.9%],  sinusitis [2.9%]) and 56 (62.2%) patients had deep infec-
tion  (pneumonia [26.8%], arthritis [17.9%], pyodermitis [14.3%],
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Table 1 – Comparison of patients with community-acquired methicillin-resistant and methicillin-susceptible
Staphylococcus aureus infection.
Characteristic MRSA (n = 6) MSSA (n = 84) p
Male gendera 2 (33.3) 57 (67.9) 0.2
Age
<2 yearsa 4 (66.7) 41 (48.8) 0.7
Median (25th–75th percentile) 5.4 mo (16d–5.1yr) 26.4 mo (6.5 mo–6.3yr) 0.2
Hospitalizationa 6 (100) 72 (85.7) 1
Chronic underlying illnessesa 4 (66.7) 23 (27.4) 0.06
Skina 1 (16.7) 11 (13.1) 0.6
Hearta 1 (16.7) 6 (7.1) 0.4
Respiratory tracta 0 3 (3.6) 1
Malnutritiona 2 (33.3) 10  (11.9) 0.2
Deep  infectiona 6 (100) 50 (59.5) 0.08
Sterile ﬂuida 5 (83.3) 61 (72.6) 1
Evolution
Deatha 1 (16.7) 1 (1.2) 0.1
Intensive care unita 1 (16.7) 3  (4.1) 0.3
Length  of hospitalization (days) 16 ± 11 16  ± 12 1
Complicationsa 1 (16.7) 16 (19) 1
Vancomycin usea 2 (33.3) 10 (11.9) 0.2
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bscess [14.3%], osteomyelitis [8.9%], adenitis [5.4%], sepsis
5.4%],  endocarditis [3.6%], cellulitis [1.8%], urinary tract infec-
ion  [1.8%]). S. aureus was  recovered from skin lesion (47.1%),
kin  abscess (41.2%), ocular secretion and nasopharyngeal or
ropharyngeal swab (5.9% each) in patients with SSTIs and
rom  blood (71.4%), abscess (10.7%), pleural effusion (5.4%),
ynovial  ﬂuid (5.4%), urine, pericardic effusion, ﬁstula secre-
ion  and intra-abdominal lymph node (1.8% each) in patients
ith  deep-seated infections.
Among the 78 hospitalized cases, two (2.6%) died and the
edian  (days) (25th–75th percentile) length of hospitalization
or  the others was  14 (7–22), range 1–53. All were  discharged
fter improvement. Among the 12 outpatients studied, one
8.3%)  was  hospitalized for seven days and discharged; all of
hem  also improved. Four (5.1%) patients were transferred to
he ICU and their mean stay (days) there was  3.5 (±1.3) days,
ange  (2–5). The mean interval (days) between hospitalization
nd admission to the ICU was  2.5 (1.3), range (1–4). For the pur-
ose  of the analysis presented herein, the outpatient who was
ospitalized  was  added to the group of hospitalized patients.
omplications were  detected in 17 (18.9%) cases including
leural effusion (41.2%), osteomyelitis (23.5%), sepsis (17.6%),
espiratory  insufﬁciency (11.8%), arthritis, cellulitis, ﬁstula,
ericarditis, septic shock (5.9% each). Three patients presented
ore  than one complication. None had sequelae and one
atient  with arthritis was  not followed-up after being dis-
harged.
Approximately 93% of the cases had received systemic
ntibiotics. Initially, 59 (65.5%) patients were  treated with
xacillin  or cefalotin, to whom aminoglycosides (n = 20), cef-
riaxone  (n = 2), aqueous penicillin G (n = 1) were  also given.
wenty-ﬁve cases (28%) used other antibiotic regiments: other
enicillins  (e.g. aqueous penicillin G, benzathine penicillin
r  amoxicillin) [13.3%], aminoglycosides [5.6%], trimethoprim-
ulfamethoxazole (TMP-SMX) [5.6%], ceftriaxone, vancomycinand a combination of ceftriaxone and aminoglycoside [1.1%
each].  Twenty-three (27.4%) children had their ﬁrst antimi-
crobial  regimen changed to: vancomycin (43.6%) or oxacillin
(34.8%),  erythromycin (8.7%), TMP-SMX, ceftriaxone and clin-
damycin  (4.3% each). Only one patient had the antibiotic
regimen changed for the second time; in this case oxacillin
was  switched to vancomycin. Six (6.7%) MRSA strains were
detected  according to the aforementioned microbiologic crite-
ria.  Table 1 shows the comparison between the patients with
MRSA  or MSSA infection. Four patients did not use van-
comycin as a therapeutic option, even though MRSA was
isolated  from their blood. The clinical features of these four
cases  are summarized in Table 2.
Discussion
In the present study, we did not observe higher mor-
bidity or mortality rates among patients with CA-MRSA
infection when they were compared with patients who
had  CA-MSSA infection. In Korea, MRSA was  not found
to  be signiﬁcantly associated with higher mortality among
adults.15 However, other studies have described the associ-
ation  between CA-MRSA strains and worse outcomes. A prior
report  documented the presence of CA-MRSA isolates causing
necrotizing  pneumonia and severe sepsis.16 Another inves-
tigation  demonstrated that CA-MRSA osteomyelitis had a
longer  duration of hospitalization compared with osteomyeli-
tis  caused by CA-MSSA strains in children.17 Furthermore, it
is  important to emphasize that CA-MSSA infections are also
found  to be prevalent among life-threatening staphylococcal
infections. This statement is consistent with some published
data  suggesting that CA-MSSA isolates are more  likely than
CA-MRSA  isolates to be associated with invasive infections.8
Nevertheless, a recent analysis showed severe clinical course
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Table 2 – Patients with community-acquired methicillin-resistant S. aureus bacteremia without vancomycin use.
Characteristic Case I Case II Case III Case IV
Date of admission 8 May 1996 18 September 1996 2 August 2004 10 October 2005
Age 14 days 16 days 36 months 5 months
Gender Female Female Female Male
Underlying illness None Congenital heart disease Sickle cell disease None
Diagnosis at presentation Pneumonia Pneumonia Dactylitis Pyodermitis
Other site of S. aureus isolation No No No No
Initial antibiotic regimen Cep & Ami Pen G & Ami None Oxa
Subsequent antibiotic regimen None Oxa None None
Length of hospitalization (days) 19 12 7 15
Complications None None None None
Outcome Resolution Resolution Resolution Resolution
Antimicrobial testing
Susceptible Ami, Cip, Tei Gen, Rif, Tei, TMP-SMX, Van Ami, Cip, Cli, Ery,
Gen,  Rif, Tei, Van
Ami,  Cip, Ery, Gen, Tei,
TMP-SMX,  Van
Resistant Ery, Gen Ami, Ery TMP-SMX –
, eryt
oxazoAmi, amikacin; Cep, cefalotin; Cip, ciproﬂoxacin; Cli, clindamycin; Ery
G; Rif, rifampin; Tei, teicoplanin; TMP-SMX, trimethoprim-sulfameth
in both CA-MSSA and CA-MRSA pneumonia. Days of oxygen
requirement and intubations were  similar between MRSA and
MSSA  infected children.9 It is increasingly recognized that
Panton-Valentine leukocidin-positive S. aureus is associated
with  highly aggressive disease, irrespective of antimicrobial
resistance.18
Interestingly, we  found four bacteremic patients infected
with  MRSA who  improved despite not receiving vancomycin.
It  is important to state that in spite of the recognized viru-
lent  nature of MRSA bacteremia, not all bacteremic patients
experience complications.19 A risk-scoring system was  cre-
ated  to estimate the likelihood of developing complications
among patients with S. aureus bacteremia.20 Persistent fever at
72 h, positive result of follow-up blood culture at 48–96 h, skin
ﬁndings  of acute systemic infection and community-acquired
infection are the individual risk factors included in the score.
Except  for the S. aureus community origin, all other factors
were  not present among those four bacteremic cases sum-
marized  in Table 2. It is useful to classify CA-SA infections as
MRSA  and MSSA, but this is not necessarily predictive of S.
aureus  virulence.21
In this context, one can suspect that several of our MRSA
strains  were  not really resistant to methicillin. However,
the  disc-diffusion method as outlined by the Clinical and
Laboratory Standards Institute (CLSI) was  used to detect
antimicrobial resistance and methicillin resistance was con-
ﬁrmed  by the ability of the isolates to grow on Mueller-Hinton
agar supplemented with 5% sodium chloride and 1 g
oxacillin, incubated at 35 ◦C.12 The CLSI deﬁnes the disc-
diffusion test with oxacillin as a reliable method to detect
MRSA.  Other techniques are also available, such as the cefox-
itin  disc screen test and the latex agglutination test for PBP2a.
When  used correctly, all three methods usually can detect
MRSA  strains accurately.22,23
In our analysis, MRSA was  isolated from 6 (6.7%) of 90 eligi-
ble  CA-SA cases. Data reported in other studies showed higher
frequency  (37%) of CA-MRSA strains.24 The use of healthcare-
associated risk factors in the inclusion criteria in studies of
CA-MRSA  epidemiology may  explain these disparate results. Ahromycin; Gen, gentamicin; Oxa, oxacillin; Pen G, aqueous penicillin
le; Van, vancomycin.
previous meta-analysis including different CA-MRSA publica-
tions  documented that the prevalence of MRSA isolates among
people  without risk factors (genuine CA-MRSA) remains low,
which  is consistent with our ﬁnding.25 So, it must be empha-
sized  that in some studies found in the literature the majority
of  those MRSA isolates were not really CA strains.26 In the
present  report, we were able to contact patients’ families with
CA-MRSA  to verify any healthcare risk factor that might have
been  missed in medical records. Thus, we can assure the
genuine  community origin of isolates enrolled in this inves-
tigation  according to the updated 2010 CDC  deﬁnition.10
SSTIs are by far the most common clinical manifestations
of CA-SA infections in children and adults.27,28 However, this
ﬁnding  has not been demonstrated in our analysis. SSTIs were
responsible  for 34 (37.8%) cases of CA-SA infections. The great
majority  of our patients have experienced invasive infections
(62.2%).  It is important to note that this investigation was  con-
ducted  in a tertiary care center and children admitted to our
institution  might have presented the worse spectrum of dis-
ease,  which required hospitalization.
The  limitations of this study must be emphasized. Firstly,
the  retrospective design had intrinsic limitations, including
incomplete medical charts. This was  overcome by telephone
contact.  Secondly, the number of patients with CA-MRSA
infection was  small. This ﬁnding may  have been inﬂuenced
by  the strict criteria used for the classiﬁcation of CA-SA
infection10 with the purpose of detecting genuine CA-SA infec-
tion.  Moreover, it is a ﬁnding by itself. Thirdly, during the
analysis,  we did not address additional bacterial characteris-
tics,  including clonal types and virulence factors of the strains.
This  further investigation could add to the understanding
of the distinct clinical course and therapeutic response of
S.  aureus strains, especially in invasive infections.4 Fourthly,
recall  bias may  have occurred because the phone call was  per-
formed  between October 2010 and July 2011 and the patients
had  S. aureus isolated between 1995 and 2004. But as the phone
call  searched for sequelae and sequelae are permanent, it
is  not probable that recall bias have occurred in regard to
sequelae.  Concerning healthcare-associated risk factors (any
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f the following conditions during the year before infection:
ospitalization, admission to a nursing home, skilled nursing
acility,  or hospice; dialysis; or surgery; the patient must be
ithout  permanent indwelling catheters or medical devices
hat  pass through the skin into the body) that were also
earched for in the previous year to S. aureus isolation, they
re  not usually easy to be forgotten. Therefore, recall bias is
nlikely.
In  conclusion, this study attempted to describe the char-
cteristics of CA-SA infections among children in a tertiary
are  center. We  found no relevant differences on baseline
haracteristics or on the outcome of patients infected with CA-
RSA or CA-MSSA strains. In addition, the evidence presented
erein  supports the occurrence of genuine CA-MRSA in our
egion.  Although it is clinically still signiﬁcant to classify CA-
A  as MSSA and MRSA, the clinicians should be aware of the
road  epidemiology of S. aureus infections.29 Both CA-MRSA
nd  CA-MSSA strains may  result in life-threatening disease or
ethal events.
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